Skip to main content
Equibles

Allworth Financial LP

Position in TLX — Telix Pharmaceuticals Ltd

CIK 1555170 FOLSOM, CA
Back to TLX Full portfolio

Position in TLX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$5
+$1 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 62 holders
Holding Since
Mar 2026
2 quarters on record

Common Shares in TLX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Allworth Financial LP holds $18,666,310 across 285 Biotechnology names. TLX ranks #279 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 37,664 $2,947,961
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,487 $2,228,827
3 MDGL
Madrigal Pharmaceuticals, Inc.
 3,562 $1,912,615
4 REGN
Regeneron Pharmaceuticals, Inc.
 2,530 $1,577,556
5 INCY
Incyte Corp
 5,182 $587,431
6 EXEL
Exelixis, Inc.
 10,562 $574,678
7 CRSP
CRISPR Therapeutics AG
 10,089 $550,254
8 RVMD
Revolution Medicines, Inc.
 2,240 $419,507

All Filings in TLX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5 0
2026-03-31 $4 0